Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113200860B reveals high-purity SGLT2 inhibitor intermediate via flow chemistry. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN113548971A reveals a novel reductive amination route for spermidine. This process offers significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN111041515B reveals a metal-free electrochemical route for high-purity quinoxalinone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103641879A details a novel chemical route for prednisolone intermediates using plant sterols, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Novel patent CN104193689A offers cost-effective Erlotinib synthesis. Avoids palladium catalysts. Ensures supply chain stability for pharmaceutical intermediates.
Novel patent CN118146139A offers mild conditions for 4-amino-1-methylpiperidine. Reduces cost and supply risk for pharma intermediates manufacturing.
Novel nickel-photocatalyzed method for (R)-1,3-diarylbutene offers mild conditions and high enantioselectivity, ensuring cost-effective supply chain solutions for pharmaceutical intermediates.
Novel catalytic route for cis-bicyclo [3.1.0] hex-3-ol reduces cost and improves safety for pharmaceutical intermediates manufacturing supply chains.
Patent CN104072500A details a novel synthesis for quinoxaline imidazolium salts. This route offers significant supply chain stability and cost reduction in catalyst ligand manufacturing for global partners.
Patent CN110590644B details a metal-free one-pot cascade method for chiral 1,2-dihydropyridines, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed route for cis-fused beta-lactam compounds. Enhances supply chain reliability and reduces manufacturing costs for antibiotic intermediates.
Novel silver triflate method improves yield and stability for high-purity pharmaceutical intermediates supply chain optimization.
Novel Leuckart reaction route improves yield and purity for Alzheimer's drug intermediates, offering cost-effective manufacturing solutions.
Patent CN106278965B details a copper-catalyzed method for aryl-alkyl asymmetric persulfides. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Novel route for Dapoxetine HCl using chiral organocatalyst. High yield, >99% ee. Ideal for API intermediates and cost reduction in pharmaceutical manufacturing.
Patent CN112679336A reveals a green heterogeneous Pd@POL catalytic route for phenylpropionic acids, offering reduced heavy metal residues and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN107311959A details a green iodine-catalyzed route for 2-aminobenzothiazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediate suppliers.
Patent CN102875444A details a Cu-catalyzed route for oxindoles. Offers high purity, mild conditions, and scalable manufacturing for pharma intermediates.
Patent CN110256211B reveals a photoredox method for 1,1-diarylalkane derivatives. Offers mild conditions and cost reduction in fine chemical manufacturing for global supply chains.
Patent CN101402582A reveals a novel one-step four-component reaction for high-purity pharmaceutical intermediates. This method significantly reduces cost and improves supply chain reliability.